These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lessons learned from 2 years experience in intravenous thrombolysis for acute ischemic stroke in a single tertiary medical center. Gur AY, Shopin L, Bornstein NM. Isr Med Assoc J; 2009 Dec; 11(12):714-6, 718. PubMed ID: 20166336 [Abstract] [Full Text] [Related]
30. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial. Bounameaux H, Banga JD, Bluhmki E, Coccheri S, Fiessinger JN, Haarmann W, Lockner D, Mahler F, Ninet J, Schneider PA. Thromb Haemost; 1992 Mar 02; 67(3):306-9. PubMed ID: 1641820 [Abstract] [Full Text] [Related]
32. [Local intra-arterial thrombolysis with low dosage rt-PA. Thrombolysis in arterial occlusive disease of the leg]. Weidauer T, Timmermann J. Fortschr Med; 1990 Dec 20; 108(36):700-2. PubMed ID: 2128294 [Abstract] [Full Text] [Related]
33. [Systemic venous thrombolysis with rt-PA in arterial embolism of the legs in the elderly]. Marci M, Panzini E, Lozzi A, Russo F. Clin Ter; 1996 Dec 20; 147(7-8):371-6. PubMed ID: 9118619 [Abstract] [Full Text] [Related]
34. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator. Berridge DC, Earnshaw JJ, Westby JC, Makin GS, Hopkinson BR. Thromb Haemost; 1989 Apr 25; 61(2):275-8. PubMed ID: 2501898 [Abstract] [Full Text] [Related]
35. Outcome and complications after intra-arterial thrombolysis for lower limb ischaemia with or without continuous heparin infusion. Grip O, Kuoppala M, Acosta S, Wanhainen A, Åkeson J, Björck M. Br J Surg; 2014 Aug 25; 101(9):1105-12. PubMed ID: 24965149 [Abstract] [Full Text] [Related]
36. Intra-arterial thrombolytic therapy in the management of acute and chronic limb ischaemia. Barr H, Lancashire MJ, Torrie EP, Galland RB. Br J Surg; 1991 Mar 25; 78(3):284-7. PubMed ID: 2021840 [Abstract] [Full Text] [Related]
37. Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in acute lower limb ischaemia. Flis V, Kobilica N, Bergauer A, Mrdža B, Milotič F, Štirn B. J Int Med Res; 2011 Mar 25; 39(3):1107-12. PubMed ID: 21819745 [Abstract] [Full Text] [Related]
38. Percutaneous site-specific pharmacomechanical thrombolysis- thrombectomy system for bilateral acute limb ischemia. Gupta R, Gautam A, Hennebry TA. J Invasive Cardiol; 2011 Feb 25; 23(2):81-3. PubMed ID: 21297206 [Abstract] [Full Text] [Related]
39. The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy. Wong YS, Sung SF, Wu CS, Hsu YC, Su YH, Hung LC, Ong CT. Drug Des Devel Ther; 2020 Feb 25; 14():257-263. PubMed ID: 32021109 [Abstract] [Full Text] [Related]
40. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Sullivan KL, Gardiner GA, Shapiro MJ, Bonn J, Levin DC. Radiology; 1989 Dec 25; 173(3):805-8. PubMed ID: 2813789 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]